Acyclovir does not reduce threat of HIV transmission for folks infected with both HIV and HSV-2 A five-year international multi-center clinical trial has discovered that acyclovir, a drug widely used as a effective and safe treatment taken twice daily to suppress herpes simplex virus-2 , which is the most common cause of genital herpes, does not reduce the threat of HIV tranny when taken by people contaminated with both HSV-2 and HIV. Today The results of the study are published in the brand new England Journal of Medicine online, and will come in the Feb. 4, 2010 issue of the publication levitra . Up to 90 percent of individuals with HIV infection also have HSV-2 infection. Most people who are contaminated with HSV-2 have no idea they have the virus because symptoms can be gentle or absent.
‘We believe strongly in the effectiveness of a mutually beneficial partnership and appearance forward to working with Mazor to meet the requirements of japan government to get the necessary approvals and deliver this advanced technology to Japan.’ ‘The distribution contract and initial purchase order from Adachi signifies an important stage in expanding the marketplace for Renaissance in Asia,’ said Ori Hadomi, CEO of Mazor. ‘Adachi can be an 80 year-old family-owned business that has established relationships with leading hospitals and medical agencies. It has significant knowledge in distributing leading medical technology and clearing the regulatory hurdles.